• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE PROPATEN VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE PROPATEN VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER Back to Search Results
Catalog Number H050040J
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Seroma (2069)
Event Date 07/14/2021
Event Type  Injury  
Manufacturer Narrative
Additional manufacturer narrative: cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
The following was reported to gore: on unknown date in 2021, a gore® propaten® vascular graft and a thoratec vascular access graft were used in a hemodialysis shunt surgery.A design was; left brachial artery - propaten - thoratec - propaten - left basilic vein.The patient was hospitalized for a month in another hospital for cerebral hemorrhage.When the patient returned, a seroma was observed.The seroma was located 4cm from the anastomosis of the artery and was about the size of a ping-pong ball.On (b)(6) 2021, a part of propaten with seroma was replaced with a thoratec vascular access graft.The physician stated that the cerebral hemorrhage that led to the hospitalization and hypoalbuminemia was thought to be the cause of the seroma.The albumin level was 2.6 g/dl.There was no causal relationship between the cerebral hemorrhage and the propaten.
 
Manufacturer Narrative
A1 patient identifier - (b)(6).
 
Event Description
The following was reported to gore: on (b)(6) 2021, a gore® propaten® vascular graft and a thoratec vascular access graft were used in a hemodialysis shunt surgery.The devices were implanted in the left brachial artery with the propaten - thoratec - propaten and ending in the left basilic vein.The patient was hospitalized for a month in another hospital for cerebral hemorrhage.On (b)(6) 2021, a seroma was observed.The seroma was located 4cm from the anastomosis of the artery and was about the size of a ping-pong ball.On (b)(6) 2021, a part of the propaten device with seroma was replaced with a thoratec vascular access graft.
 
Manufacturer Narrative
B7: preexisting conditions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE PROPATEN VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key12271433
MDR Text Key264976155
Report Number2017233-2021-02218
Device Sequence Number1
Product Code DSY
Combination Product (y/n)Y
PMA/PMN Number
K062161
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup
Report Date 10/01/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberH050040J
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/21/2021
Initial Date FDA Received08/03/2021
Supplement Dates Manufacturer Received07/21/2021
07/21/2021
Supplement Dates FDA Received09/15/2021
10/01/2021
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-